HUM
Humana Inc.Healthcare · $46.6B market cap
Verdict
Share price
$388.36
close of Oct 3, 2026
Fair value
$535.43
Sticker Price
Payback Price
$214.17
buy price
HUM is Undervalued: at $388.36 it trades 27% below its fair value of $535.43. Its buy price (Payback Price) is $214.17, 45% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow HUM
Get notified when it reaches its buy price of $214.17. Free.
Create a free accountSuperinvestors
2 of the investors we track hold HUM. In Q2 2026, 1 trimmed. Who we track
Dodge & Cox Funds
Dodge & Cox Funds · as of Q2 2026
$4.3B
10,940,380 shares
Richard Pzena
Pzena Investment Management · as of Q2 2026
$1.7B
4,403,136 shares
Moves in Q2 2026
Trimmed: Richard Pzena
Insider activity
Since Jun 30, 2026: no open-market purchases and 4 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government…
Medical - Healthcare Plans
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works